BXP.L Stock - Beximco Pharmaceuticals Limited
Unlock GoAI Insights for BXP.L
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | $44.39B | $39.27B | $34.67B | $29.49B | $25.61B |
| Gross Profit | $19.63B | $17.10B | $15.81B | $13.92B | $11.90B |
| Gross Margin | 44.2% | 43.6% | 45.6% | 47.2% | 46.5% |
| Operating Income | $8.67B | $7.22B | $6.90B | $6.65B | $5.61B |
| Net Income | $5.83B | $4.61B | $5.12B | $5.13B | $3.51B |
| Net Margin | 13.1% | 11.8% | 14.8% | 17.4% | 13.7% |
| EPS | $13.07 | $10.34 | $11.48 | $11.49 | $7.88 |
Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulation products and active pharmaceutical ingredients in Bangladesh. The company offers allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies. It provides its products in various dosage forms, including solid, liquid, cream and ointment, suppositories, metered dose and dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids. The company also exports its products. Beximco Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Dhaka, Bangladesh.
Visit WebsiteEarnings History & Surprises
BXP.LEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Jan 27, 2026 | — | — | — | — |
Q4 2025 | Nov 18, 2025 | — | — | — | — |
Q2 2025 | Jun 3, 2025 | — | — | — | — |
Q2 2025 | May 29, 2025 | — | — | — | — |
Q1 2025 | Jan 28, 2025 | — | $0.03 | — | — |
Q4 2024 | Nov 7, 2024 | — | — | — | — |
Q2 2024 | Jun 30, 2024 | — | $0.02 | — | — |
Q2 2024 | Apr 30, 2024 | — | $0.02 | — | — |
Q1 2024 | Jan 30, 2024 | — | $0.02 | — | — |
Q3 2023 | Sep 30, 2023 | — | $0.03 | — | — |
Q2 2023 | Jun 30, 2023 | — | $0.02 | — | — |
Q1 2023 | Mar 31, 2023 | — | $0.02 | — | — |
Q4 2022 | Dec 31, 2022 | — | $0.02 | — | — |
Q3 2022 | Sep 30, 2022 | — | $0.03 | — | — |
Q2 2022 | Jun 30, 2022 | — | $0.02 | — | — |
Q1 2022 | Mar 31, 2022 | — | $0.02 | — | — |
Q4 2021 | Dec 31, 2021 | — | $0.03 | — | — |
Q3 2021 | Sep 30, 2021 | — | $0.03 | — | — |
Q2 2021 | Jun 30, 2021 | — | $0.03 | — | — |
Q1 2021 | Mar 31, 2021 | — | $0.03 | — | — |
Latest News
Frequently Asked Questions about BXP.L
What is BXP.L's current stock price?
What is the analyst price target for BXP.L?
What sector is Beximco Pharmaceuticals Limited in?
What is BXP.L's market cap?
Does BXP.L pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to BXP.L for comparison